IntroductionOur company provides worldwide analyze reports and thespecialization in company financials, company profiles, SWOTanalysis, company reports, company statistics, strategy review,industry reports, energy reports, medical reports, Market Size,Market Profile, Survey Brief, Market Databook, Survey Snapshot etc.Aarkstore Enterprise, originally established in 2008, concentrateson providing online market research information & services to topcompanies. We are connected with worldwide market researchpartners like Koncept Analytics, Wintergreen Research,Datamonitor, Global Data, TriMark Publications, Timetric,WealthInsight, RI TECHNOLOGIES, MarketsandMarkets etc.
CategoryOur Latest Pharmaceutical & Healthcare Discounted reports: Orthopedic Devices Market to 2017 - Spinal Surgery and Advanced Prosthetics Products to be Major Growth Driver Peripheral Vascular Devices Market to 2018 - Increasing Demand for Minimally Invasive Endovascular Procedures Presents Growth Opportunities for Manufacturers Surgical Equipment Market to 2018 - Increased Access to Ambulatory Surgical Centers to Drive Outpatient Surgery Volumes Renal Dialysis Equipment - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018 Surgical Sutures - Global Opportunity Assessment, Competitive Landscape and Market Forecasts to 2018 More Reports……………..
Report prizeBiolubricants Market - Global Scenario, Trends, Industry Analysis, Size, Share And Forecast, 2010 - 2018 Pages : 75 $ 4595 - PDF | $ 7595 - Multi-user Licence | $ 10595 - Enterprise License
Summary • Global Markets Direct’s, Insulin Resistance - Pipeline Review, H2 2012,provides an overview of the indication’s therapeutic pipeline. This reportprovides information on the therapeutic development for InsulinResistance, complete with latest updates, and special features on late-stageand discontinued projects. It also reviews key players involved in thetherapeutic development for Insulin Resistance. Insulin Resistance -Pipeline Review, Half Year is built using data and information sourced fromGlobal Markets Direct’s proprietary databases, Company/Universitywebsites, SEC filings, investor presentations and featured press releasesfrom company/university sites and industry-specific third party sources,put together by Global Markets Direct’s team. Note*: Certain sections in the report may be removed or altered based onthe availability and relevance of data for the indicated disease.
Table of ContentsList of Tables 6List of Figures 6Introduction 7Global Markets Direct Report Coverage 7Insulin Resistance Overview 8Therapeutics Development 9An Overview of Pipeline Products for Insulin Resistance 9Insulin Resistance Therapeutics under Development by Companies 11Insulin Resistance Therapeutics under Investigation by Universities/Institutes12Late Stage Products 15Comparative Analysis 15Mid Clinical Stage Products 16Comparative Analysis 16Early Clinical Stage Products 17Comparative Analysis 17 More……………